Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project.
about
Vitamin E supplementation and macular degeneration: randomised controlled trial.The potential role of amyloid beta in the pathogenesis of age-related macular degeneration.The Tehran Eye Study: research design and eye examination protocolDrusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degenerationDissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degenerationNew treatments in age-related macular degeneration.Revision of visual impairment definitions in the International Statistical Classification of DiseasesWhat is the global burden of visual impairment?A review of drug options in age-related macular degeneration therapy and potential new agents.Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM Study.Prevalence and causes of low vision and blindness in an urban population: The Chennai Glaucoma Study.The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.Visual acuity and associated factors. The Central India Eye and Medical Study.Characteristics of 681 low vision patients in Korea.Nine-year refractive changes in the Barbados Eye StudiesRacial disparities in uncorrected and undercorrected refractive error in the United StatesSocioeconomic status and blindnessPrevention of age-related macular degenerationNature and nurture: the complex genetics of myopia and refractive error.Vision impairment and dual sensory problems in middle age.Familial aggregation of hyperopia in an elderly population of siblings in Salisbury, MarylandGenomewide scan in Ashkenazi Jewish families demonstrates evidence of linkage of ocular refraction to a QTL on chromosome 1p36.How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.The prevalence and causes of visual impairment in Tehran: the Tehran Eye Study.Visual acuity in northern China in an urban and rural population: the Beijing Eye Study.Prevalence and causes of blindness in the rural population of the Chennai Glaucoma StudyAge Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study.Surface-Based Analyses of Anatomical Properties of the Visual Cortex in Macular Degeneration.The Prevalence and Causes of Visaual Impairment and Blindness in a Rural Population in the North of Iran.Comparison of the efficacy of anti-VEGF monotherapy versus PDT and intravitreal anti-VEGF combination treatment in AMD: a Meta-analysis and systematic reviewVisual impairment in the 40- to 64-year-old population of Shahroud, IranNumber of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-AnalysisThe value of corneal transplantation in reducing blindness.Australian Angiogram Review Panel--monitoring the use of photodynamic therapy with verteporfin.Eye disorders in old peopleChronic oxidative stress upregulates Drusen-related protein expression in adult human RPE stem cell-derived RPE cells: a novel culture model for dry AMD.Overview of progress in the epidemiology of age-related macular degeneration.Narrowing the gap between eye care needs and service provision: the service-training nexusNecessity of Periodic Ophthalmological Examinations in Binocular B Class Driving Licence Holders Over 50 Years of Age.
P2860
Q24531484-C5642AB9-890F-405D-870E-1829232497B1Q24532130-9045D492-C0DC-43FB-9E21-38527DA17CBCQ24792500-DA3EADC6-8264-420D-965A-696667C114EAQ28590177-F3F9117C-D40B-475A-9452-9CF3B9CA7477Q28769548-6917D0C0-92EA-4D1D-931A-FA4DD5AF2304Q31004243-91BBD46B-087F-49B4-8D49-954E199B0CF0Q33236647-DFCC5DA5-B32F-4251-B6BC-8C549A1978D2Q33236655-9039A9B6-6BE9-4266-82D3-C0D5A4AAE6EFQ33263803-33192D68-7652-4C7E-8659-9E2122B9FB00Q33395089-E0C6A953-8ECD-488A-9F41-958E5AFD40D2Q33780710-481B0091-3C95-46A7-9637-C92E52F0E60AQ33855388-70B1CF53-7233-49A8-BFEC-6957CE03C8A2Q33987826-E223FEC2-687B-457D-965A-EE4EA12EDDD4Q34014816-FB307C8C-EA48-44D9-B994-D03EA31F985EQ34195793-28AC175D-B922-49B5-9AFB-1C0D77B6408DQ34433590-26BC4218-FD46-43FC-A91C-653A040AE721Q34457601-0D7D8E80-3961-4D42-93CD-3EFBD959F9A4Q34491498-2A7EA610-29C3-494D-8F47-ACC99F186FBCQ34679031-523337CB-3762-47E6-9D40-11B9615AFDE0Q34755728-C6B809F5-C246-400F-8403-14D51FBFD63BQ35008983-48DA6329-68D3-4D89-B8CA-855F25722C57Q35070567-E5BFC793-342E-4AC7-ABBE-E9204E7F38D0Q35070975-8D6F4162-7257-4CBB-AA9D-A10F121D4552Q35162123-812C1E83-E3C0-4086-A132-63848A3DF07AQ35592087-46B9CA5F-DDCA-45EB-A5B1-C0735A90927DQ35593694-D80528AA-A1C7-443C-956B-0BC0216C1443Q35761734-7A071505-47B8-4A94-B329-94C91C9E3F46Q35768952-119781A3-B46C-4578-868A-065235A6ADFAQ35898857-6E8388B5-2832-4968-83A3-8C219B3E9978Q35914552-9E7DC245-010C-4D6C-963B-EC6314C861B1Q36097244-1305D336-6AC5-464F-AE0F-886D08F20539Q36167224-73666D76-A45E-4208-A29E-D85F23957039Q36168951-87E10CC7-C2E4-4443-A0FD-B2475DABE0B5Q36320416-4416C0A0-1380-461F-960A-53B73343781FQ36574035-7A47BB40-86B9-40D0-AB2A-9193C94088C1Q36648305-916A48B2-BEE1-40E3-B45A-7093DC74C342Q36739408-582A5B30-1BD4-48BD-AEF5-91B291EF3EE1Q36951800-43C0E8BC-D451-425B-AFEE-B309D64527EFQ37177065-FCE7013C-CFC6-4895-B5F8-6FB4E8598DFDQ37370428-500E12FD-D8BA-46C9-B4AA-40E61A8C4061
P2860
Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Cause-specific prevalence of b ...... the Visual Impairment Project.
@en
Cause-specific prevalence of b ...... the Visual Impairment Project.
@nl
type
label
Cause-specific prevalence of b ...... the Visual Impairment Project.
@en
Cause-specific prevalence of b ...... the Visual Impairment Project.
@nl
prefLabel
Cause-specific prevalence of b ...... the Visual Impairment Project.
@en
Cause-specific prevalence of b ...... the Visual Impairment Project.
@nl
P1433
P1476
Cause-specific prevalence of b ...... the Visual Impairment Project.
@en
P2093
P304
P356
10.1016/S0161-6420(01)00554-1
P577
2001-05-01T00:00:00Z